Ding, Ruilin
Chen, Longxia
Li, Xinghai
Xiong, Tengqiong
Chen, Hong
Hu, Xiaojing
Li, Yun
Zhou, Yi
Liu, Kezhi
Wu, Jianhong
Jiang, Feng
Peng, Qing https://orcid.org/0000-0003-1372-1993
Funding for this research was provided by:
Hinova Pharmaceuticals Inc.
Article History
Accepted: 7 May 2023
First Online: 30 May 2023
Declarations
:
: This study was sponsored by Hinova Pharmaceuticals Inc. (Chengdu, China).
: Xinghai Li and Yi Zhou are employees of Hinova Pharmaceuticals Inc. The other authors declare no conflicts of interest.
: The study protocol and informed consent forms were reviewed and approved by the institutional ethics committee of the Affiliated Hospital of Southwest Medical University (Luzhou, China, approval number: L2021027). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: All participants provided written informed consent before participation in the study.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Study conception and/or design: QP, XL, FJ. Data acquisition: RD, LC, TX, HC, XH, YL, KL, JW. Data analysis: RD, LC, XL. Interpretation of results: RD, LC, XL, YZ, QP. All authors were involved in the review and approval of the manuscript and in the decision to submit the article for publication. All authors also confirm accountability for the accuracy and integrity of the work.